The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Arch Oncology; Bristol-Myers Squibb/Celgene; Epizyme; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Lilly; Sanofi
Consulting or Advisory Role - Arch Oncology; Bristol-Myers Squibb/Celgene; Epizyme; GlaxoSmithKline; Karyopharm Therapeutics; Lilly; Sanofi
Speakers' Bureau - Janssen; Karyopharm Therapeutics
Research Funding - Amgen; GlaxoSmithKline; Sanofi
Perceptions of prognosis in caregivers of multiple myeloma (MM) patients.
 
Yael N. Shapiro
No Relationships to Disclose
 
Omar Nadeem
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; Janssen; Sanofi; Takeda
 
Andrew Jenho Yee
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Sanofi
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Takeda (Inst)
 
Jacob Laubach
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); CARsgen Therapeutics (Inst); Genentech (Inst); Janssen Research & Development (Inst); Millennium (Inst)
 
Andrew R. Branagan
Consulting or Advisory Role - Genzyme; Pharmacyclics/Janssen; Surface Oncology
 
Kenneth Carl Anderson
Stock and Other Ownership Interests - C4 Therapeutics; OncoPep
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Oncology; Millennium; Precision Biosciences; Sanofi; Tolero Pharmaceuticals
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep
 
Clifton C. Mo
No Relationships to Disclose
 
Nikhil C. Munshi
Stock and Other Ownership Interests - OncoPep
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; BeiGene; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; OncoPep; Takeda
Patents, Royalties, Other Intellectual Property - Oncopep
 
Irene M. Ghobrial
Honoraria - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Cellectar; Janssen; Karyopharm Therapeutics; Medscape; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; GNS Healthcare; Janssen; Karyopharm Therapeutics; Medscape; Novartis; Noxxon Pharma; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Takeda
 
Adam Samuel Sperling
No Relationships to Disclose
 
Michelle M. Mesa
No Relationships to Disclose
 
Jill N. Burke
No Relationships to Disclose
 
Cynthia C. Harrington
Consulting or Advisory Role - Sanofi
 
Emerentia A. Agyemang
No Relationships to Disclose
 
Lisette R. Packer
No Relationships to Disclose
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda
Research Funding - Bluebird Bio (Inst)
 
Areej El-Jawahri
No Relationships to Disclose
 
Elizabeth O'Donnell
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - BMS; Celgene; Sanofi
Research Funding - Amgen (Inst); Takeda (Inst)